November 17, 2022 by Chain Drug Review
Genexa
Supplier News
ATLANTA – Families concerned about rising respiratory syncytial virus (RSV) and flu cases in the United States have a new potential obstacle to worry about – what appears to be an emerging shortage of infants’ and kids’ pain relievers and fever reducers, which first impacted Canada and now seems to be a growing concern in the United States.
April 27, 2022 by Chain Drug Review
Genexa, Genexa Acetaminophen Extra Strength has 500mg of the pain reliever acetaminophen and Genexa Acetaminophen PM has 500mg of the pain reliever acetaminophen and 25 mg of diphenhydramine HCl.
Supplier News
ATLANTA – Adults can opt for a clean alternative with the same efficacy as its counterparts in the medicine aisles. Launched Wednesday, Genexa’s Acetaminophen Extra Strength and Acetaminophen PM caplets have the same active ingredients and dosages of current category leaders but without artificial dyes, synthetic fillers and other artificial preservatives. Genexa Acetaminophen Extra Strength
March 8, 2022 by Chain Drug Review
Fast Company’s prestigious annual list of the World’s Most Innovative Companies, Genexa
Leading Headlines, Supplier News
ATLANTA, Ga. – Genexa has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. Genexa makes over-the-counter (O-T-C) medicines with the same active ingredients as category leaders but without any of the unnecessary artificial ingredients – including artificial preservatives, dyes, and sweeteners – plus contains no common allergens. These innovations
February 17, 2022 by Chain Drug Review
Emily Culp, Genexa
Leading Headlines, Supplier News
ATLANTA – Genexa has appointed Emily Culp as the company’s new chief marketing officer (CMO). Culp will lead all branding, marketing and eCommerce for Genexa, bringing with her more than two decades of experience in marketing and eCommerce and a proven track record in accelerating growth by building consumer-centric brands across channels and geographies, driving
July 14, 2021 by Chain Drug Review
Genexa
Leading Headlines, Supplier News
ATLANTA – Genexa has just completed its unprecedented $60 million Series A of funding to advance its market leadership in this emerging space. Marking a seminal development in the consumer healthcare industry, Genexa’s oversubscribed campaign was the largest Series A ever raised for an O-T-C medicine company, substantiating the dramatic shift of consumers looking for
October 14, 2020 by Chain Drug Review
David Johnson, Genexa
Supplier News
ATLANTA — Medicine cabinets all over the country are loaded with products that contain artificial sweeteners, dyes and preservatives, plus fillers such as wood pulp, aluminum, talc, lactose, gluten, and other ingredients that research from MIT and Brigham and Women’s Hospital has shown is potentially harmful. To encourage people to clean out the “dirty” from their medicine
September 29, 2020 by Chain Drug Review
Brian Perkins, cold medicine, David Johnson, Genexa, Giovanni Traverso, Max Spielberg
Supplier News
ATLANTA — Genexa has launched the of its first-to-market clean medicine line for kids and adults. The company reports that medicine has the same active ingredients people need for safe, effective relief of symptoms, but without the artificial ones they don’t. Cold and flu season is fast approaching and nearly 7 in 10 parents turn